Arritmias no idoso: avaliaçao através da eletrocardiografia dinâmica de 24 horas

Alteraçoes do ritmo cardíaco podem ser encontradas normalmente em indivíduos saudáveis; o avançar da idade, entretanto, aumenta sua prevalência. Para identificar a freqüência de arritmias em idosos sadios e naqueles portadores de doenças cardiovasculares, foram analisados os resultados dos exames de Eletrocardiografia Dinâmica de 24 horas realizados em 288 indivíduos, sendo 159 (55,2%) do sexo feminino e 129 (44,8%) do sexo masculino, com idade mínima de 60 anos (máxima de 97 e média de 70 anos). Tais pacientes foram divididos em seis grupos, de acordo com os seus diagnósticos: 1) sem cardiopatia aparente, 2) com hipertensao arterial sistêmica, 3) com doença arterial coronária, 4) com prolapso de valva mitral, 5) com miocardiopatias e 6) com valvulopatias. As arritmias supraventriculares estiveram presentes em 55,6% dos pacientes estudados (extrassístoles em 38%, taquicardia atrial em 8,7% e ritmos ectópicos em 4,9%) e as arritmias ventriculares ocorreram em 31 % (extrassístoles em 29,6% e taquicardia nao-sustentada em 1,4%). Bradiarritmias foram registradas em 6,9% dos casos. Dos 191 que apresentaram arritmias, 67,5% nao relatavam quaisquer sintomas, enquanto que dos 32,5% que os referiram, em apenas 3,2% os mesmos estavam associados às arritmias. Os resultados do estudo confirmaram que as alteraçoes do ritmo cardíaco no idoso sao comuns e freqüentemente assintomáticas, nao havendo diferença significativa em relaçao à presença ou nao de doença cardiovascular

Arritmias no idoso: avaliaçao através da eletrocardiografia dinâmica de 24 horas

Alteraçoes do ritmo cardíaco podem ser encontradas normalmente em indivíduos saudáveis; o avançar da idade, entretanto, aumenta sua prevalência. Para identificar a freqüência de arritmias em idosos sadios e naqueles portadores de doenças cardiovasculares, foram analisados os resultados dos exames de Eletrocardiografia Dinâmica de 24 horas realizados em 288 indivíduos, sendo 159 (55,2%) do sexo feminino e 129 (44,8%) do sexo masculino, com idade mínima de 60 anos (máxima de 97 e média de 70 anos). Tais pacientes foram divididos em seis grupos, de acordo com os seus diagnósticos: 1) sem cardiopatia aparente, 2) com hipertensao arterial sistêmica, 3) com doença arterial coronária, 4) com prolapso de valva mitral, 5) com miocardiopatias e 6) com valvulopatias. As arritmias supraventriculares estiveram presentes em 55,6% dos pacientes estudados (extrassístoles em 38%, taquicardia atrial em 8,7% e ritmos ectópicos em 4,9%) e as arritmias ventriculares ocorreram em 31 % (extrassístoles em 29,6% e taquicardia nao-sustentada em 1,4%). Bradiarritmias foram registradas em 6,9% dos casos. Dos 191 que apresentaram arritmias, 67,5% nao relatavam quaisquer sintomas, enquanto que dos 32,5% que os referiram, em apenas 3,2% os mesmos estavam associados às arritmias. Os resultados do estudo confirmaram que as alteraçoes do ritmo cardíaco no idoso sao comuns e freqüentemente assintomáticas, nao havendo diferença significativa em relaçao à presença ou nao de doença cardiovascular

A“Dirty” Footprint: Macroinvertebrate diversity in Amazonian Anthropic Soils

International audienceAmazonian rainforests, once thought to be pristine wilderness, are increasingly known to have been widely inhabited, modified, and managed prior to European arrival, by human populations with diverse cultural backgrounds. Amazonian Dark Earths (ADEs) are fertile soils found throughout the Amazon Basin, created by pre-Columbian societies with sedentary habits. Much is known about the chemistry of these soils, yet their zoology has been neglected. Hence, we characterized soil fertility, macroinvertebrate communities, and their activity at nine archeological sites in three Amazonian regions in ADEs and adjacent reference soils under native forest (young and old) and agricultural systems. We found 673 morphospecies and, despite similar richness in ADEs (385 spp.) and reference soils (399 spp.), we identified a tenacious pre-Columbian footprint, with 49% of morphospecies found exclusively in ADEs. Termite and total macroinvertebrate abundance were higher in reference soils, while soil fertility and macroinvertebrate activity were higher in the ADEs, and associated with larger earthworm quantities and biomass. We show that ADE habitats have a unique pool of species, but that modern land use of ADEs decreases their populations, diversity, and contributions to soil functioning. These findings support the idea that humans created and sustained high-fertility ecosystems that persist today, altering biodiversity patterns in Amazonia

Mapping 123 million neonatal, infant and child deaths between 2000 and 2017

Since 2000, many countries have achieved considerable success in improving child survival, but localized progress remains unclear. To inform efforts towards United Nations Sustainable Development Goal 3.2—to end preventable child deaths by 2030—we need consistently estimated data at the subnational level regarding child mortality rates and trends. Here we quantified, for the period 2000–2017, the subnational variation in mortality rates and number of deaths of neonates, infants and children under 5 years of age within 99 low- and middle-income countries using a geostatistical survival model. We estimated that 32% of children under 5 in these countries lived in districts that had attained rates of 25 or fewer child deaths per 1,000 live births by 2017, and that 58% of child deaths between 2000 and 2017 in these countries could have been averted in the absence of geographical inequality. This study enables the identification of high-mortality clusters, patterns of progress and geographical inequalities to inform appropriate investments and implementations that will help to improve the health of all populations

Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019 : A systematic analysis for the Global Burden of Disease Study 2019

Background Achieving universal health coverage (UHC) involves all people receiving the health services they need, of high quality, without experiencing financial hardship. Making progress towards UHC is a policy priority for both countries and global institutions, as highlighted by the agenda of the UN Sustainable Development Goals (SDGs) and WHO's Thirteenth General Programme of Work (GPW13). Measuring effective coverage at the health-system level is important for understanding whether health services are aligned with countries' health profiles and are of sufficient quality to produce health gains for populations of all ages. Methods Based on the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, we assessed UHC effective coverage for 204 countries and territories from 1990 to 2019. Drawing from a measurement framework developed through WHO's GPW13 consultation, we mapped 23 effective coverage indicators to a matrix representing health service types (eg, promotion, prevention, and treatment) and five population-age groups spanning from reproductive and newborn to older adults (≥65 years). Effective coverage indicators were based on intervention coverage or outcome-based measures such as mortality-to-incidence ratios to approximate access to quality care; outcome-based measures were transformed to values on a scale of 0–100 based on the 2·5th and 97·5th percentile of location-year values. We constructed the UHC effective coverage index by weighting each effective coverage indicator relative to its associated potential health gains, as measured by disability-adjusted life-years for each location-year and population-age group. For three tests of validity (content, known-groups, and convergent), UHC effective coverage index performance was generally better than that of other UHC service coverage indices from WHO (ie, the current metric for SDG indicator 3.8.1 on UHC service coverage), the World Bank, and GBD 2017. We quantified frontiers of UHC effective coverage performance on the basis of pooled health spending per capita, representing UHC effective coverage index levels achieved in 2019 relative to country-level government health spending, prepaid private expenditures, and development assistance for health. To assess current trajectories towards the GPW13 UHC billion target—1 billion more people benefiting from UHC by 2023—we estimated additional population equivalents with UHC effective coverage from 2018 to 2023. Findings Globally, performance on the UHC effective coverage index improved from 45·8 (95% uncertainty interval 44·2–47·5) in 1990 to 60·3 (58·7–61·9) in 2019, yet country-level UHC effective coverage in 2019 still spanned from 95 or higher in Japan and Iceland to lower than 25 in Somalia and the Central African Republic. Since 2010, sub-Saharan Africa showed accelerated gains on the UHC effective coverage index (at an average increase of 2·6% [1·9–3·3] per year up to 2019); by contrast, most other GBD super-regions had slowed rates of progress in 2010–2019 relative to 1990–2010. Many countries showed lagging performance on effective coverage indicators for non-communicable diseases relative to those for communicable diseases and maternal and child health, despite non-communicable diseases accounting for a greater proportion of potential health gains in 2019, suggesting that many health systems are not keeping pace with the rising non-communicable disease burden and associated population health needs. In 2019, the UHC effective coverage index was associated with pooled health spending per capita (r=0·79), although countries across the development spectrum had much lower UHC effective coverage than is potentially achievable relative to their health spending. Under maximum efficiency of translating health spending into UHC effective coverage performance, countries would need to reach $1398 pooled health spending per capita (US$ adjusted for purchasing power parity) in order to achieve 80 on the UHC effective coverage index. From 2018 to 2023, an estimated 388·9 million (358·6–421·3) more population equivalents would have UHC effective coverage, falling well short of the GPW13 target of 1 billion more people benefiting from UHC during this time. Current projections point to an estimated 3·1 billion (3·0–3·2) population equivalents still lacking UHC effective coverage in 2023, with nearly a third (968·1 million [903·5–1040·3]) residing in south Asia. Interpretation The present study demonstrates the utility of measuring effective coverage and its role in supporting improved health outcomes for all people—the ultimate goal of UHC and its achievement. Global ambitions to accelerate progress on UHC service coverage are increasingly unlikely unless concerted action on non-communicable diseases occurs and countries can better translate health spending into improved performance. Focusing on effective coverage and accounting for the world's evolving health needs lays the groundwork for better understanding how close—or how far—all populations are in benefiting from UHC